"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 41 | 41 |
| 1997 | 0 | 46 | 46 |
| 1998 | 0 | 44 | 44 |
| 1999 | 0 | 55 | 55 |
| 2000 | 0 | 52 | 52 |
| 2001 | 1 | 57 | 58 |
| 2002 | 0 | 87 | 87 |
| 2003 | 0 | 111 | 111 |
| 2004 | 1 | 107 | 108 |
| 2005 | 0 | 125 | 125 |
| 2006 | 0 | 115 | 115 |
| 2007 | 0 | 134 | 134 |
| 2008 | 0 | 188 | 188 |
| 2009 | 0 | 171 | 171 |
| 2010 | 0 | 188 | 188 |
| 2011 | 0 | 230 | 230 |
| 2012 | 0 | 235 | 235 |
| 2013 | 0 | 277 | 277 |
| 2014 | 0 | 280 | 280 |
| 2015 | 1 | 299 | 300 |
| 2016 | 0 | 315 | 315 |
| 2017 | 0 | 291 | 291 |
| 2018 | 0 | 348 | 348 |
| 2019 | 0 | 331 | 331 |
| 2020 | 0 | 289 | 289 |
| 2021 | 0 | 225 | 225 |
| 2022 | 0 | 61 | 61 |
| 2023 | 0 | 67 | 67 |
| 2024 | 0 | 244 | 244 |
| 2025 | 0 | 255 | 255 |
| 2026 | 0 | 92 | 92 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
The Safety and Efficacy of Colorectal Endoscopic Submucosal Dissection in the Elderly: A Large Western Analysis of 710 Lesions. J Clin Gastroenterol. 2026 Sep 01; 60(8):715-721.
-
Symptom Tracking for Patient-Reported Outcomes in Cancer: User-Centered Design of the AthenaCompanion Web Application. J Med Internet Res. 2026 Aug 05; 28:e94017.
-
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial. Lancet Neurol. 2026 Aug; 25(8):721-730.
-
Health care use and costs associated with clinically impactful immune-related adverse events during immune checkpoint inhibitor therapy for non-small cell lung cancer. J Manag Care Spec Pharm. 2026 Aug; 32(8):979-993.
-
Metformin added to lifestyle intervention for physical function in older adults with obesity (DEMFOS trial): a randomised controlled trial. Lancet Healthy Longev. 2026 Jul; 7(7):100883.
-
Pattern of opioid prescriptions among patients with breast, lung, and colorectal cancer diagnosed with pre-existing chronic non-cancer pain. PLoS One. 2026; 21(7):e0352907.
-
FcRH5?CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial. Nat Med. 2026 Aug; 32(8):2909-2917.
-
Incidence of respiratory syncytial virus in adults =50 years during and following the COVID-19 pandemic in upper midwest USA: a community-based prospective cohort study. BMJ Open. 2026 Jul 21; 16(7):e111773.
-
Chronological versus physiological age for 10-year survival estimation: a real-world healthsystem-wide cohort analysis. EBioMedicine. 2026 Aug; 130:106371.
-
Composite arterial and venous collateral score on single-phase CTA predicts 90-day outcomes in anterior circulation large-vessel occlusion stroke. J Neurointerv Surg. 2026 Jul 16; 18(8):1749-1756.